Drug profile · INN
aminoglutethimide
CYTADREN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
aminoglutethimide (CYTADREN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN aminoglutethimide
Brand CYTADREN
Route ORAL
Formulation TABLET
Frequently asked questions
What is aminoglutethimide?
aminoglutethimide (CYTADREN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for aminoglutethimide?
CYTADREN is a marketed brand name for aminoglutethimide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of aminoglutethimide?
aminoglutethimide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.